- In April 2022, Molecular Assemblies and Codexis collaborated to create a high-performing enzyme to allow fully enzymatic synthesis of DNA.
- In February 2022, Kerry Group acquired c-LEcta to increase its expertise, manufacturing capabilities, and technology portfolio.
- In December 2021, Codexis introduced Codex HiTemp Reverse Transcriptase. This enzyme is specially optimized and engineered for improved thermostability and robustness to identify known challenges in handling clinical samples.
- In June 2021, DSM-Novozymes alliance launched a protease, ProAct 360 for poultry which helps improve feed affordability, efficiency and sustainability.
Frequently Asked Questions
Novozymes (Denmark), BASF SE (Germany), DuPont (U.S.), Associated British Foods (U.K.), DSM (Netherlands), Dyadic International Inc., (U.S.), Advanced Enzymes Technologies (India), Aumgene Biosciences (India), Chr. Hansen Holding A/S (Denmark), Amano Enzyme Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Codexis, Inc. (U.S.), Sanofi (France), Creative Enzymes (U.S.), Enzyme Solutions (U.S.), Enzymatic Deinking Technologies, LLC (U.S.), Biocatalysts (U.K.) are the major companies in the enzymes market.
In April 2022, Molecular Assemblies and Codexis collaborated to create a high-performing enzyme to allow fully enzymatic synthesis of DNA.
The countries covered in the busway market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
